Regulation of an epitope-tagged recombinant Rsk-1 S6 kinase by phorbol ester and erk/MAP kinase - PubMed (original) (raw)

. 1993 Aug 3;32(30):7727-38.

doi: 10.1021/bi00081a018.

Affiliations

• PMID: 7688567
• DOI: 10.1021/bi00081a018

Regulation of an epitope-tagged recombinant Rsk-1 S6 kinase by phorbol ester and erk/MAP kinase

J R Grove et al. Biochemistry. 1993.

Abstract

Phorbol ester tumor promoters (TPA) activate the endogenous erk/MAP kinases and Rsk S6 kinases but not the p70S6 kinase in COS cells. DNA sequences encoding the rat Rsk-1 S6 kinase (homologous to Xenopus rsk alpha), modified by insertion of a peptide epitope at the polypeptide aminoterminus, were expressed transiently in COS cells. TPA stimulates the 40S and peptide kinase activity of the recombinant epitope-tagged Rsk-1, as well as the extent of Rsk-1 autophosphorylation in vitro (32P-Ser >> 32P-Thr). Indications that the conformation of the recombinant Rsk-1 polypeptide is substantially changed after activation by TPA in situ include a retarded mobility of the Rsk-1 polypeptide on SDS-PAGE and the appearance of new 32P-peptides during autophosphorylation in vitro. All these features of the TPA-activated Rsk-1 S6 kinase are abolished by dephosphorylation of the kinase in vitro with Ser/Thr phosphatase-2A. TPA increases 32P incorporation into recombinant Rsk-1 by 2-3-fold (32P-Ser >> 32P-Thr). Peptide mapping exhibits a single major 32P-peptide in Rsk-1 isolated from unstimulated cells and 10-12 additional 32P peptides after TPA treatment in situ. Phosphorylation of basal or phosphatase-2A-treated recombinant Rsk-1 in vitro with erk2/MAP kinase increases Rsk-1 40S kinase, peptide kinase, and autophosphorylating activity, retards migration of Rsk-1 polypeptides on SDS-PAGE, and generates new sites of Rsk-1 autophosphorylation in vitro. By contrast, TPA-activated Rsk-1 is not altered in these properties by autophosphorylation in vitro. By contrast, TPA-activated Rsk-1 is not altered in these properties by phosphorylation in vitro with erk2/MAP kinase. Activation of Rsk-1 in situ with TPA diminishes by over 90% the extent of Rsk-1 phosphorylation achieved in vitro by erk2/MAP kinase, as compared to the parallel phosphorylation of a phosphatase-2A-treated Rsk-1; basal Rsk-1 is intermediate. Peptide maps of phosphatase-2A-treated Rsk-1 after phosphorylation in vitro with erk2/MAP kinase exhibit 32P-peptides that comigrate with nearly all of the 32P-peptides present in TPA-activated-32P Rsk-1 labeled in situ, plus several 32P-peptides characteristic of Rsk-1 autophosphorylation in vitro.(ABSTRACT TRUNCATED AT 400 WORDS)

PubMed Disclaimer

Similar articles

• Sequential activation of MAP kinase activator, MAP kinases, and S6 peptide kinase in intact rat liver following insulin injection.
  Tobe K, Kadowaki T, Hara K, Gotoh Y, Kosako H, Matsuda S, Tamemoto H, Ueki K, Akanuma Y, Nishida E, et al. Tobe K, et al. J Biol Chem. 1992 Oct 15;267(29):21089-97. J Biol Chem. 1992. PMID: 1328222
• Insulin activates a 70-kDa S6 kinase through serine/threonine-specific phosphorylation of the enzyme polypeptide.
  Price DJ, Gunsalus JR, Avruch J. Price DJ, et al. Proc Natl Acad Sci U S A. 1990 Oct;87(20):7944-8. doi: 10.1073/pnas.87.20.7944. Proc Natl Acad Sci U S A. 1990. PMID: 2122450 Free PMC article.
• Role and regulation of 90 kDa ribosomal S6 kinase (RSK) in signal transduction.
  Frödin M, Gammeltoft S. Frödin M, et al. Mol Cell Endocrinol. 1999 May 25;151(1-2):65-77. doi: 10.1016/s0303-7207(99)00061-1. Mol Cell Endocrinol. 1999. PMID: 10411321 Review.
• Autophosphorylation: a salient feature of protein kinases.
  Smith JA, Francis SH, Corbin JD. Smith JA, et al. Mol Cell Biochem. 1993 Nov;127-128:51-70. doi: 10.1007/BF01076757. Mol Cell Biochem. 1993. PMID: 7935362 Review.

Cited by

• Suppression of DNA-damage checkpoint signaling by Rsk-mediated phosphorylation of Mre11.
  Chen C, Zhang L, Huang NJ, Huang B, Kornbluth S. Chen C, et al. Proc Natl Acad Sci U S A. 2013 Dec 17;110(51):20605-10. doi: 10.1073/pnas.1306328110. Epub 2013 Dec 2. Proc Natl Acad Sci U S A. 2013. PMID: 24297933 Free PMC article.
• RSK1 drives p27Kip1 phosphorylation at T198 to promote RhoA inhibition and increase cell motility.
  Larrea MD, Hong F, Wander SA, da Silva TG, Helfman D, Lannigan D, Smith JA, Slingerland JM. Larrea MD, et al. Proc Natl Acad Sci U S A. 2009 Jun 9;106(23):9268-73. doi: 10.1073/pnas.0805057106. Epub 2009 May 22. Proc Natl Acad Sci U S A. 2009. PMID: 19470470 Free PMC article.
• Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics.
  Hennessy BT, Gonzalez-Angulo AM, Stemke-Hale K, Gilcrease MZ, Krishnamurthy S, Lee JS, Fridlyand J, Sahin A, Agarwal R, Joy C, Liu W, Stivers D, Baggerly K, Carey M, Lluch A, Monteagudo C, He X, Weigman V, Fan C, Palazzo J, Hortobagyi GN, Nolden LK, Wang NJ, Valero V, Gray JW, Perou CM, Mills GB. Hennessy BT, et al. Cancer Res. 2009 May 15;69(10):4116-24. doi: 10.1158/0008-5472.CAN-08-3441. Epub 2009 May 12. Cancer Res. 2009. PMID: 19435916 Free PMC article.
• p90 ribosomal S6 kinase and p70 ribosomal S6 kinase link phosphorylation of the eukaryotic chaperonin containing TCP-1 to growth factor, insulin, and nutrient signaling.
  Abe Y, Yoon SO, Kubota K, Mendoza MC, Gygi SP, Blenis J. Abe Y, et al. J Biol Chem. 2009 May 29;284(22):14939-48. doi: 10.1074/jbc.M900097200. Epub 2009 Mar 30. J Biol Chem. 2009. PMID: 19332537 Free PMC article.
• AG490 influences UCN-01-induced cytotoxicity in glioma cells in a p53-dependent fashion, correlating with effects on BAX cleavage and BAD phosphorylation.
  Jane EP, Premkumar DR, Pollack IF. Jane EP, et al. Cancer Lett. 2007 Nov 8;257(1):36-46. doi: 10.1016/j.canlet.2007.06.020. Cancer Lett. 2007. PMID: 17900801 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Other Literature Sources

  • The Lens - Patent Citations Database

• Molecular Biology Databases

  • GlyGen glycoinformatics resource

• Miscellaneous

  • NCI CPTAC Assay Portal